BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection. Front Cell Neurosci 2017;11:338. [PMID: 29163050 DOI: 10.3389/fncel.2017.00338] [Cited by in Crossref: 117] [Cited by in F6Publishing: 108] [Article Influence: 29.3] [Reference Citation Analysis]
Number Citing Articles
1 Karas BF, Hotz JM, Buckley BT, Cooper KR. Cisplatin alkylating activity in zebrafish causes resistance to chorionic degradation and inhibition of osteogenesis. Aquat Toxicol 2020;229:105656. [PMID: 33075613 DOI: 10.1016/j.aquatox.2020.105656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tserga E, Moreno-Paublete R, Sarlus H, Björn E, Guimaraes E, Göritz C, Cederroth CR, Canlon B. Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea. FASEB J 2020;34:13978-92. [PMID: 32840016 DOI: 10.1096/fj.202001236R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
3 Gentilin E, Simoni E, Candito M, Cazzador D, Astolfi L. Cisplatin-Induced Ototoxicity: Updates on Molecular Targets. Trends in Molecular Medicine 2019;25:1123-32. [DOI: 10.1016/j.molmed.2019.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
4 Liang Q, Shen N, Lai B, Xu C, Sun Z, Wang Z, Li S. Electrical Stimulation Degenerated Cochlear Synapses Through Oxidative Stress in Neonatal Cochlear Explants. Front Neurosci 2019;13:1073. [PMID: 31680814 DOI: 10.3389/fnins.2019.01073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Hashem MA, Shoeeb SB, Abd-elhakim YM, Mohamed WA. The antitumor activity of Arthrospira platensis and/or cisplatin in a murine model of Ehrlich ascites carcinoma with hematinic and hepato-renal protective action. Journal of Functional Foods 2020;66:103831. [DOI: 10.1016/j.jff.2020.103831] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
6 Pak JH, Kim Y, Yi J, Chung JW. Antioxidant Therapy against Oxidative Damage of the Inner Ear: Protection and Preconditioning. Antioxidants (Basel) 2020;9:E1076. [PMID: 33147893 DOI: 10.3390/antiox9111076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Han H, Dong Y, Ma X. Dihydromyricetin Protects Against Gentamicin-Induced Ototoxicity via PGC-1α/SIRT3 Signaling in vitro. Front Cell Dev Biol 2020;8:702. [PMID: 32850822 DOI: 10.3389/fcell.2020.00702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Canis M, Bertlich M. Cochlear Capillary Pericytes. Adv Exp Med Biol 2019;1122:115-23. [PMID: 30937866 DOI: 10.1007/978-3-030-11093-2_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Mizuta Y, Tokuda K, Guo J, Zhang S, Narahara S, Kawano T, Murata M, Yamaura K, Hoka S, Hashizume M, Akahoshi T. Sodium thiosulfate prevents doxorubicin-induced DNA damage and apoptosis in cardiomyocytes in mice. Life Sci 2020;257:118074. [PMID: 32673667 DOI: 10.1016/j.lfs.2020.118074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
10 Tang Q, Wang X, Jin H, Mi Y, Liu L, Dong M, Chen Y, Zou Z. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies. Eur J Pharm Biopharm 2021;163:60-71. [PMID: 33775853 DOI: 10.1016/j.ejpb.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hojan-Jezierska D, Chomiak A, Czopor A, Matthews-Kozanecka M, Majewska A, Urbaniak-Olejnik M, Matthews-Brzozowska T. Ototoxicity after platinum-based chemotherapy in the treatment of melanotic neuroectodermal tumour of infancy. Oncol Lett 2020;19:3411-6. [PMID: 32269613 DOI: 10.3892/ol.2020.11447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lee CH, Lee DH, Lee SM, Kim ASY. Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity. Int J Mol Sci 2020;21:E3503. [PMID: 32429117 DOI: 10.3390/ijms21103503] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Kitcher SR, Kirkwood NK, Camci ED, Wu P, Gibson RM, Redila VA, Simon JA, Rubel EW, Raible DW, Richardson GP, Kros CJ. ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity. JCI Insight 2019;4:126764. [PMID: 31391343 DOI: 10.1172/jci.insight.126764] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
14 Moos WH, Faller DV, Glavas IP, Harpp DN, Irwin MH, Kanara I, Pinkert CA, Powers WR, Steliou K, Vavvas DG, Kodukula K. A New Approach to Treating Neurodegenerative Otologic Disorders. Biores Open Access 2018;7:107-15. [PMID: 30069423 DOI: 10.1089/biores.2018.0017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Waissbluth S. Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far? Eur Arch Otorhinolaryngol 2020;277:2413-22. [PMID: 32358651 DOI: 10.1007/s00405-020-06003-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
16 Estfanous RS, Elseady WS, Kabel AM, Abd Ellatif RA. Amelioration of Cisplatin-Induced Ototoxicity in Rats by L-arginine: The Role of Nitric Oxide, Transforming Growth Factor Beta 1 and Nrf2/HO-1 Pathway. Asian Pac J Cancer Prev 2020;21:2155-62. [PMID: 32711445 DOI: 10.31557/APJCP.2020.21.7.2155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Fregonezi NF, Aparecida de Souza F, Aleixo NA, Stefany da Silva Gomes P, Silvestre RB, De Grandis RA, Bento da Silva P, Pavan FR, Chorilli M, Resende FA. Cyto-genotoxic evaluation of novel anti-tubercular copper (II) complexes containing isoniazid-based ligands. Regulatory Toxicology and Pharmacology 2020;113:104653. [DOI: 10.1016/j.yrtph.2020.104653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Minasian LM, Frazier AL, Sung L, O'Mara A, Kelaghan J, Chang KW, Krailo M, Pollock BH, Reaman G, Freyer DR. Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials. Cancer Med 2018. [PMID: 29846043 DOI: 10.1002/cam4.1563] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
19 Domarecka E, Skarzynska M, Szczepek AJ, Hatzopoulos S. Use of zebrafish larvae lateral line to study protection against cisplatin-induced ototoxicity: A scoping review. Int J Immunopathol Pharmacol 2020;34:2058738420959554. [PMID: 33084473 DOI: 10.1177/2058738420959554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mukherjea D, Dhukhwa A, Sapra A, Bhandari P, Woolford K, Franke J, Ramkumar V, Rybak L. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity. Expert Opin Drug Metab Toxicol 2020;16:965-82. [PMID: 32757852 DOI: 10.1080/17425255.2020.1806235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
21 Choi MJ, Kang H, Lee YY, Choo OS, Jang JH, Park SH, Moon JS, Choi SJ, Choung YH. Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis. Cells 2019;8:E409. [PMID: 31052605 DOI: 10.3390/cells8050409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
22 Monroe JD, Moolani SA, Irihamye EN, Johnston AM, Smith ME. Effects of L-Serine Against Cisplatin-Mediated Reactive Oxygen Species Generation in Zebrafish Vestibular Tissue Culture and HEI-OC1 Auditory Hybridoma Cells. Neurotox Res 2021;39:36-41. [PMID: 32221851 DOI: 10.1007/s12640-020-00188-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Guan G, He X, Chen J, Bin L, Tang X. Identifying the mechanisms underlying the protective effect of tetramethylpyrazine against cisplatin‑induced in vitro ototoxicity in HEI‑OC1 auditory cells using gene expression profiling. Mol Med Rep 2020;22:5053-68. [PMID: 33174043 DOI: 10.3892/mmr.2020.11631] [Reference Citation Analysis]
24 Rybak LP, Mukherjea D, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention. Semin Hear 2019;40:197-204. [PMID: 31036996 DOI: 10.1055/s-0039-1684048] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
25 Santos NAGD, Ferreira RS, Santos ACD. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food Chem Toxicol 2020;136:111079. [PMID: 31891754 DOI: 10.1016/j.fct.2019.111079] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
26 Tserga E, Nandwani T, Edvall NK, Bulla J, Patel P, Canlon B, Cederroth CR, Baguley DM. The genetic vulnerability to cisplatin ototoxicity: a systematic review. Sci Rep 2019;9:3455. [PMID: 30837596 DOI: 10.1038/s41598-019-40138-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
27 Waissbluth S, Del Valle Á, Chuang A, Becker A. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients. International Journal of Pediatric Otorhinolaryngology 2018;111:174-9. [DOI: 10.1016/j.ijporl.2018.06.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Meijer AJM, Li KH, Brooks B, Clemens E, Ross CJ, Rassekh SR, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM, Carleton BC. The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Cancer 2021. [PMID: 34490624 DOI: 10.1002/cncr.33848] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Fox E, Levin K, Zhu Y, Segers B, Balamuth N, Womer R, Bagatell R, Balis F. Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin. Oncologist 2018;23:762-e79. [PMID: 29445029 DOI: 10.1634/theoncologist.2018-0037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
30 Paciello F, Fetoni AR, Mezzogori D, Rolesi R, Di Pino A, Paludetti G, Grassi C, Troiani D. The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity. Sci Rep 2020;10:1063. [PMID: 31974389 DOI: 10.1038/s41598-020-57965-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 24.0] [Reference Citation Analysis]
31 Liu W, Xu L, Wang X, Zhang D, Sun G, Wang M, Wang M, Han Y, Chai R, Wang H. PRDX1 activates autophagy via the PTEN-AKT signaling pathway to protect against cisplatin-induced spiral ganglion neuron damage. Autophagy 2021;:1-23. [PMID: 33749526 DOI: 10.1080/15548627.2021.1905466] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
32 Chen Y, Gu J, Liu J, Tong L, Shi F, Wang X, Wang X, Yu D, Wu H. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity. Int J Nanomedicine 2019;14:4211-27. [PMID: 31239676 DOI: 10.2147/IJN.S195336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
33 Mei H, Zhao L, Li W, Zheng Z, Tang D, Lu X, He Y. Inhibition of ferroptosis protects House Ear Institute-Organ of Corti 1 cells and cochlear hair cells from cisplatin-induced ototoxicity. J Cell Mol Med 2020;24:12065-81. [PMID: 32929878 DOI: 10.1111/jcmm.15839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
34 Kim DU, Kim DG, Choi JW, Shin JY, Kweon B, Zhou Z, Lee HS, Song HJ, Bae GS, Park SJ. Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice. Int J Mol Sci 2021;22:1421. [PMID: 33572597 DOI: 10.3390/ijms22031421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lui G, Bouazza N, Denoyelle F, Moine M, Brugières L, Chastagner P, Corradini N, Entz-Werle N, Vérité C, Landmanparker J, Sudour-Bonnange H, Pasquet M, Verschuur A, Faure-Conter C, Doz F, Tréluyer JM. Association between genetic polymorphisms and platinum-induced ototoxicity in children. Oncotarget 2018;9:30883-93. [PMID: 30112115 DOI: 10.18632/oncotarget.25767] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
36 Chen Y, Bielefeld EC, Mellott JG, Wang W, Mafi AM, Yamoah EN, Bao J. Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity. J Assoc Res Otolaryngol 2021;22:107-26. [PMID: 33415542 DOI: 10.1007/s10162-020-00782-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Paken J, Govender CD, Pillay M, Ayele BT, Sewram V. Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity. BMC Womens Health 2021;21:164. [PMID: 33879158 DOI: 10.1186/s12905-021-01313-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Metal Drugs and the Anticancer Immune Response. Chem Rev 2019;119:1519-624. [DOI: 10.1021/acs.chemrev.8b00396] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 36.0] [Reference Citation Analysis]
39 Negrette-Guzmán M. Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy. Eur J Pharmacol 2019;859:172513. [PMID: 31260654 DOI: 10.1016/j.ejphar.2019.172513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
40 Rybak LP, Dhukhwa A, Mukherjea D, Ramkumar V. Local Drug Delivery for Prevention of Hearing Loss. Front Cell Neurosci 2019;13:300. [PMID: 31338024 DOI: 10.3389/fncel.2019.00300] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
41 Eshraghi AA, Ocak E, Zhu A, Mittal J, Davies C, Shahal D, Bulut E, Sinha R, Shah V, Perdomo MM, Mittal R. Biocompatibility of Bone Marrow-Derived Mesenchymal Stem Cells in the Rat Inner Ear following Trans-Tympanic Administration. J Clin Med 2020;9:E1711. [PMID: 32498432 DOI: 10.3390/jcm9061711] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Azzam P, Mroueh M, Francis M, Daher AA, Zeidan YH. Radiation-induced neuropathies in head and neck cancer: prevention and treatment modalities. Ecancermedicalscience 2020;14:1133. [PMID: 33281925 DOI: 10.3332/ecancer.2020.1133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Pham TNM, Jeong SY, Kim DH, Park YH, Lee JS, Lee KW, Moon IS, Choung SY, Kim SH, Kang TH, Jeong KW. Protective Mechanisms of Avocado Oil Extract Against Ototoxicity. Nutrients 2020;12:E947. [PMID: 32235401 DOI: 10.3390/nu12040947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
44 Gentilin E, Cani A, Simoni E, Chicca M, Di Paolo ML, Martini A, Astolfi L. Hydrogen peroxide toxicity on auditory cells: An in vitro study. Chem Biol Interact 2021;345:109575. [PMID: 34228970 DOI: 10.1016/j.cbi.2021.109575] [Reference Citation Analysis]
45 Lu J, Liu H, Lin S, Li C, Wu H. Electrophysiological characterization of acutely isolated spiral ganglion neurons in neonatal and mature sonic hedgehog knock-in mice. Neurosci Lett 2020;714:134536. [PMID: 31589904 DOI: 10.1016/j.neulet.2019.134536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Chen Y, Zhang Y, Song W, Zhang Y, Dong X, Tan M. Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1. Anticancer Agents Med Chem 2020;20:495-503. [PMID: 31814556 DOI: 10.2174/1871520619666191209091230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
47 Jian B, Pang J, Xiong H, Zhang W, Zhan T, Su Z, Lin H, Zhang H, He W, Zheng Y. Autophagy-dependent ferroptosis contributes to cisplatin-induced hearing loss. Toxicol Lett 2021;350:249-60. [PMID: 34302894 DOI: 10.1016/j.toxlet.2021.07.010] [Reference Citation Analysis]
48 Meijer AJM, Diepstraten FA, Langer T, Broer L, Domingo IK, Clemens E, Uitterlinden AG, de Vries ACH, van Grotel M, Vermeij WP, Ozinga RA, Binder H, Byrne J, van Dulmen-den Broeder E, Garrè ML, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, Kepakova K, Tissing WJE, van der Kooi ALF, Kremer LCM, Kruseova J, Pluijm SMF, Kuehni CE, van der Pal HJH, Parfitt R, Spix C, Tillmanns A, Deuster D, Matulat P, Calaminus G, Hoetink AE, Elsner S, Gebauer J, Haupt R, Lackner H, Blattmann C, Neggers SJCMM, Rassekh SR, Wright GEB, Brooks B, Nagtegaal AP, Drögemöller BI, Ross CJD, Bhavsar AP, Am Zehnhoff-Dinnesen AG, Carleton BC, Zolk O, van den Heuvel-Eibrink MM; PanCareLIFE Consortium., and the CPNDS Consortium. TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ Precis Oncol 2021;5:64. [PMID: 34262104 DOI: 10.1038/s41698-021-00178-z] [Reference Citation Analysis]
49 Kador PF, Salvi R. Multifunctional Redox Modulators Protect Auditory, Visual, and Cognitive Function. Antioxid Redox Signal 2021. [PMID: 34162214 DOI: 10.1089/ars.2021.0129] [Reference Citation Analysis]
50 Bader K, Dierkes L, Braun LH, Gummer AW, Dalhoff E, Zelle D. Test-retest reliability of distortion-product thresholds compared to behavioral auditory thresholds. Hear Res 2021;406:108232. [PMID: 33984603 DOI: 10.1016/j.heares.2021.108232] [Reference Citation Analysis]
51 Gauvin DV, Yoder J, Zimmermann ZJ, Tapp R. Ototoxicity: The Radical Drum Beat and Rhythm of Cochlear Hair Cell Life and Death. Int J Toxicol 2018;37:195-206. [PMID: 29575954 DOI: 10.1177/1091581818761128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
52 Nan B, Gu X, Huang X. The Role of the Reactive Oxygen Species Scavenger Agent, Astaxanthin, in the Protection of Cisplatin-Treated Patients Against Hearing Loss. Drug Des Devel Ther 2019;13:4291-303. [PMID: 31908415 DOI: 10.2147/DDDT.S212313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Ferraro G, Mansour AM, Merlino A. Exploring the interactions between model proteins and Pd( ii ) or Pt( ii ) compounds bearing charged N , N -pyridylbenzimidazole bidentate ligands by X-ray crystallography. Dalton Trans 2018;47:10130-8. [DOI: 10.1039/c8dt01663a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
54 Jen HI, Hill MC, Tao L, Sheng K, Cao W, Zhang H, Yu HV, Llamas J, Zong C, Martin JF, Segil N, Groves AK. Transcriptomic and epigenetic regulation of hair cell regeneration in the mouse utricle and its potentiation by Atoh1. Elife 2019;8:e44328. [PMID: 31033441 DOI: 10.7554/eLife.44328] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
55 Wu P, Wu X, Zhang C, Chen X, Huang Y, Li H. Hair Cell Protection from Ototoxic Drugs. Neural Plast 2021;2021:4909237. [PMID: 34335732 DOI: 10.1155/2021/4909237] [Reference Citation Analysis]
56 Hodeify R, Siddiqui SS, Matar R, Vazhappilly CG, Merheb M, Al Zouabi H, Marton J. Modulation of calcium-binding proteins expression and cisplatin chemosensitivity by calcium chelation in human breast cancer MCF-7 cells. Heliyon 2021;7:e06041. [PMID: 33532651 DOI: 10.1016/j.heliyon.2021.e06041] [Reference Citation Analysis]
57 Rosati R, Shahab M, Neumann WL, Jamesdaniel S. Inhibition of protein nitration prevents cisplatin-induced inactivation of STAT3 and promotes anti-apoptotic signaling in organ of Corti cells. Exp Cell Res 2019;381:105-11. [PMID: 31078568 DOI: 10.1016/j.yexcr.2019.05.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
58 Hazlitt RA, Min J, Zuo J. Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss. J Med Chem 2018;61:5512-24. [PMID: 29361217 DOI: 10.1021/acs.jmedchem.7b01653] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
59 Seah JWK, Lee JXT, Li Y, Pullarkat SA, Tan NS, Leung PH. Chelating Phosphine-N-Heterocyclic Carbene Platinum Complexes via Catalytic Asymmetric Hydrophosphination and Their Cytotoxicity Toward MKN74 and MCF7 Cancer Cell Lines. Inorg Chem 2021;60:17276-87. [PMID: 34709031 DOI: 10.1021/acs.inorgchem.1c02625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Wróblewska-Łuczka P, Grabarska A, Florek-Łuszczki M, Plewa Z, Łuszczki JJ. Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells. Int J Mol Sci 2021;22:E537. [PMID: 33430369 DOI: 10.3390/ijms22020537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
61 Meijer AJM, Clemens E, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM. Tinnitus during and after childhood cancer: A systematic review. Crit Rev Oncol Hematol 2019;135:1-7. [PMID: 30819438 DOI: 10.1016/j.critrevonc.2019.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
62 Cortés Fuentes IA, Burotto M, Retamal MA, Frelinghuysen M, Caglevic C, Gormaz JG. Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy. Free Radic Biol Med 2020;160:263-76. [PMID: 32827639 DOI: 10.1016/j.freeradbiomed.2020.07.035] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Ertilav K, Nazıroğlu M, Ataizi ZS, Yıldızhan K. Melatonin and Selenium Suppress Docetaxel-Induced TRPV1 Activation, Neuropathic Pain and Oxidative Neurotoxicity in Mice. Biol Trace Elem Res 2021;199:1469-87. [PMID: 32578137 DOI: 10.1007/s12011-020-02250-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
64 Liu T, Zong S, Luo P, Qu Y, Wen Y, Du P, Xiao H. Enhancing autophagy by down-regulating GSK-3β alleviates cisplatin-induced ototoxicity in vivo and in vitro. Toxicology Letters 2019;313:11-8. [DOI: 10.1016/j.toxlet.2019.05.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
65 Hung G, Wu C, Chou Y, Chien C, Horng J, Lin L. Cisplatin exposure impairs ionocytes and hair cells in the skin of zebrafish embryos. Aquatic Toxicology 2019;209:168-77. [DOI: 10.1016/j.aquatox.2019.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
66 Baguley DM, Prayuenyong P. Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Cancer Chemother Pharmacol 2020;85:245-50. [PMID: 31865419 DOI: 10.1007/s00280-019-04012-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
67 Di Y, Xu T, Tian Y, Ma T, Qu D, Wang Y, Lin Y, Bao D, Yu L, Liu S, Wang A. Ursolic acid protects against cisplatin‑induced ototoxicity by inhibiting oxidative stress and TRPV1‑mediated Ca2+‑signaling. Int J Mol Med 2020;46:806-16. [PMID: 32626955 DOI: 10.3892/ijmm.2020.4633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
68 Kim SY, Wee JH, Min C, Yoo DM, Choi HG. Sudden Sensorineural Hearing Loss Associated with Nutritional Anemia: A Nested Case-Control Study Using a National Health Screening Cohort. Int J Environ Res Public Health 2020;17:E6478. [PMID: 32899573 DOI: 10.3390/ijerph17186478] [Reference Citation Analysis]
69 Hao C, Wu X, Zhou R, Zhang H, Zhou Y, Wang X, Feng Y, Mei L, He C, Cai X, Wu L. Downregulation of p66Shc can reduce oxidative stress and apoptosis in oxidative stress model of marginal cells of stria vascularis in Sprague Dawley rats. Drug Des Devel Ther 2019;13:3199-206. [PMID: 31686782 DOI: 10.2147/DDDT.S214918] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
70 Wang W, Shanmugam MK, Xiang P, Yam TYA, Kumar V, Chew WS, Chang JK, Ali MZB, Reolo MJY, Peh YX, Karim SNBA, Tan AYY, Sanda T, Sethi G, Herr DR. Sphingosine 1-Phosphate Receptor 2 Induces Otoprotective Responses to Cisplatin Treatment. Cancers (Basel) 2020;12:E211. [PMID: 31952197 DOI: 10.3390/cancers12010211] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
71 Ruhl D, Du TT, Wagner EL, Choi JH, Li S, Reed R, Kim K, Freeman M, Hashisaki G, Lukens JR, Shin JB. Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity. J Neurosci 2019;39:2951-64. [PMID: 30733218 DOI: 10.1523/JNEUROSCI.1384-18.2019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
72 Sun C, Yao Y, Zhang C, Tong D, Xie B. EPO Attenuates Cisplatin-Induced Ototoxicity in HEI-OC1 Auditory Cell Via the Nrf2-ARE Signaling Pathway. Otology & Neurotology 2019;40:965-71. [DOI: 10.1097/mao.0000000000002288] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
73 Jiang M, Taghizadeh F, Steyger PS. Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity. Front Cell Neurosci 2017;11:362. [PMID: 29209174 DOI: 10.3389/fncel.2017.00362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
74 Gersten BK, Fitzgerald TS, Fernandez KA, Cunningham LL. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents. J Assoc Res Otolaryngol 2020;21:303-21. [PMID: 32583132 DOI: 10.1007/s10162-020-00759-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
75 Zheng Y, Deng Z, Tang M, Xiao D, Cai P. Impact of genetic factors on platinum-induced gastrointestinal toxicity. Mutat Res Rev Mutat Res 2020;786:108324. [PMID: 33339576 DOI: 10.1016/j.mrrev.2020.108324] [Reference Citation Analysis]
76 Campbell KCM, Le Prell CG. Drug-Induced Ototoxicity: Diagnosis and Monitoring. Drug Saf 2018;41:451-64. [PMID: 29404977 DOI: 10.1007/s40264-017-0629-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
77 Tanaka M, Hasegawa S, Nakao S, Shimada K, Mukai R, Matsumoto K, Nakamura M. Analysis of drug-induced hearing loss by using a spontaneous reporting system database. PLoS One 2019;14:e0217951. [PMID: 31593579 DOI: 10.1371/journal.pone.0217951] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
78 Lee H, Kim Y, Lee I, Kim U, Baek J, Lee K. KL1333, a derivative of β-lapachone, protects against cisplatin-induced ototoxicity in mouse cochlear cultures. Biomedicine & Pharmacotherapy 2020;126:110068. [DOI: 10.1016/j.biopha.2020.110068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Videhult Pierre P, Fransson A, Kisiel MA, Damberg P, Nikkhou Aski S, Andersson M, Hällgren L, Laurell G. Middle Ear Administration of a Particulate Chitosan Gel in an in vivo Model of Cisplatin Ototoxicity. Front Cell Neurosci 2019;13:268. [PMID: 31293387 DOI: 10.3389/fncel.2019.00268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC Jr, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, Fossa SD, Einhorn LH, Travis LB, Dolan ME. Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms. Clin Cancer Res 2019;25:4104-16. [PMID: 30952644 DOI: 10.1158/1078-0432.CCR-18-3179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
81 Annunziata A, Cucciolito ME, Esposito R, Ferraro G, Monti DM, Merlino A, Ruffo F. Five‐Coordinate Platinum(II) Compounds as Potential Anticancer Agents. Eur J Inorg Chem 2020;2020:918-29. [DOI: 10.1002/ejic.201900771] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
82 Sheth S, Sheehan K, Dhukhwa A, Al Aameri RFH, Mamillapalli C, Mukherjea D, Rybak LP, Ramkumar V. Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss. Sci Rep 2019;9:9571. [PMID: 31267026 DOI: 10.1038/s41598-019-45964-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
83 Monroe JD, Johnston AM, Smith ME. The monofunctional platinum(II) compounds, phenanthriplatin and pyriplatin, modulate apoptosis signaling pathways in HEI-OC1 auditory hybridoma cells. Neurotoxicology 2020;79:104-9. [PMID: 32413439 DOI: 10.1016/j.neuro.2020.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Fettiplace R, Nam JH. Tonotopy in calcium homeostasis and vulnerability of cochlear hair cells. Hear Res 2019;376:11-21. [PMID: 30473131 DOI: 10.1016/j.heares.2018.11.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
85 Song J, Pan R, Li G, Su W, Song X, Li J, Liu S. Synthesis and anticancer activities of thiosemicarbazones derivatives of thiochromanones and related scaffolds. Med Chem Res 2020;29:630-42. [DOI: 10.1007/s00044-020-02503-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
86 Naples JG, Ruckenstein MJ, Singh J, Cox BC, Li D. Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model. Otol Neurotol 2020;41:115-22. [PMID: 31746818 DOI: 10.1097/MAO.0000000000002417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Jung DH, Rauch SD. Clinical trials for inner ear drugs: Design and execution challenges. Hear Res 2018;368:123-6. [PMID: 29602591 DOI: 10.1016/j.heares.2018.03.020] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Ferreira NH, Furtado RA, Ribeiro AB, de Oliveira PF, Ozelin SD, de Souza LDR, Neto FR, Miura BA, Magalhães GM, Nassar EJ, Tavares DC. Europium(III)-doped yttrium vanadate nanoparticles reduce the toxicity of cisplatin. Journal of Inorganic Biochemistry 2018;182:9-17. [DOI: 10.1016/j.jinorgbio.2018.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
89 Hazlitt RA, Teitz T, Bonga JD, Fang J, Diao S, Iconaru L, Yang L, Goktug AN, Currier DG, Chen T, Rankovic Z, Min J, Zuo J. Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss. J Med Chem 2018;61:7700-9. [PMID: 30091915 DOI: 10.1021/acs.jmedchem.8b00669] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
90 Yu D, Gu J, Chen Y, Kang W, Wang X, Wu H. Current Strategies to Combat Cisplatin-Induced Ototoxicity. Front Pharmacol 2020;11:999. [PMID: 32719605 DOI: 10.3389/fphar.2020.00999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
91 Kilic K, Sakat MS, Akdemir FNE, Yildirim S, Saglam YS, Askin S. Protective effect of gallic acid against cisplatin-induced ototoxicity in rats. Brazilian Journal of Otorhinolaryngology 2019;85:267-74. [DOI: 10.1016/j.bjorl.2018.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
92 Davarpanah F, Khalili Yazdi A, Barani M, Mirzaei M, Torkzadeh-Mahani M. Magnetic delivery of antitumor carboplatin by using PEGylated-Niosomes. Daru 2018. [PMID: 30209759 DOI: 10.1007/s40199-018-0215-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
93 Szczepek AJ, Mazurek B. Neurobiology of Stress-Induced Tinnitus. Curr Top Behav Neurosci 2021;51:327-47. [PMID: 33604876 DOI: 10.1007/7854_2020_215] [Reference Citation Analysis]
94 Wang Y, Qi H, Liu Y, Duan C, Liu X, Xia T, Chen D, Piao HL, Liu HX. The double-edged roles of ROS in cancer prevention and therapy. Theranostics 2021;11:4839-57. [PMID: 33754031 DOI: 10.7150/thno.56747] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
95 Huang KM, Uddin ME, DiGiacomo D, Lustberg MB, Hu S, Sparreboom A. Role of SLC transporters in toxicity induced by anticancer drugs. Expert Opin Drug Metab Toxicol 2020;16:493-506. [PMID: 32276560 DOI: 10.1080/17425255.2020.1755253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
96 Gozeler MS, Ekinci Akdemir FN, Yildirim S, Sahin A, Eser G, Askin S. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model. Int J Pediatr Otorhinolaryngol 2019;122:70-5. [PMID: 30978472 DOI: 10.1016/j.ijporl.2019.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
97 Wang D, Shi S, Ren T, Zhang Y, Guo P, Wang J, Wang W. U0126 pretreatment inhibits cisplatin-induced apoptosis and autophagy in HEI-OC1 cells and cochlear hair cells. Toxicol Appl Pharmacol 2021;415:115447. [PMID: 33577918 DOI: 10.1016/j.taap.2021.115447] [Reference Citation Analysis]
98 Ma Y, Wise AK, Shepherd RK, Richardson RT. New molecular therapies for the treatment of hearing loss. Pharmacol Ther. 2019;200:190-209. [PMID: 31075354 DOI: 10.1016/j.pharmthera.2019.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
99 Duinkerken CW, de Weger VA, Dreschler WA, van der Molen L, Pluim D, Rosing H, Nuijen B, Hauptmann M, Beijnen JH, Balm AJM, de Boer JP, Burgers JA, Marchetti S, Schellens JHM, Zuur CL. Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial. Otol Neurotol 2021;42:678-85. [PMID: 33710154 DOI: 10.1097/MAO.0000000000003069] [Reference Citation Analysis]
100 Gao D, Yu H, Li B, Chen L, Li X, Gu W. Cisplatin Toxicology: The Role of Pro-inflammatory Cytokines and GABA Transporters in Cochlear Spiral Ganglion. CPD 2020;25:4820-6. [DOI: 10.2174/1381612825666191106143743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
101 Arenas-Jal M, Suñé-Negre JM, García-Montoya E. Therapeutic potential of nicotinamide adenine dinucleotide (NAD). Eur J Pharmacol 2020;879:173158. [PMID: 32360833 DOI: 10.1016/j.ejphar.2020.173158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
102 Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem 2019;88:102925. [PMID: 31003078 DOI: 10.1016/j.bioorg.2019.102925] [Cited by in Crossref: 204] [Cited by in F6Publishing: 184] [Article Influence: 102.0] [Reference Citation Analysis]
103 Chen Z, Zeng Z, Zhu S, Zeng Y, Lin Q, Luo L, Hong X. Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts. Sci Rep 2021;11:1040. [PMID: 33441838 DOI: 10.1038/s41598-020-80198-0] [Reference Citation Analysis]
104 Ferraro G, Giorgio A, Mansour AM, Merlino A. Protein-mediated disproportionation of Au( i ): insights from the structures of adducts of Au( iii ) compounds bearing N , N -pyridylbenzimidazole derivatives with lysozyme. Dalton Trans 2019;48:14027-35. [DOI: 10.1039/c9dt02729g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
105 Nacher-Soler G, Lenglet S, Coelho M, Thomas A, Voruz F, Krause KH, Senn P, Rousset F. Local Cisplatin Delivery in Mouse Reliably Models Sensorineural Ototoxicity Without Systemic Adverse Effects. Front Cell Neurosci 2021;15:701783. [PMID: 34335192 DOI: 10.3389/fncel.2021.701783] [Reference Citation Analysis]
106 Ahmadmehrabi S, Brant J, Epstein DJ, Ruckenstein MJ, Rader DJ. Genetics of Postlingual Sensorineural Hearing Loss. Laryngoscope 2021;131:401-9. [PMID: 32243624 DOI: 10.1002/lary.28646] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
107 Desilets A, Adam JP, Soulières D. Management of cisplatin-associated toxicities in bladder cancer patients. Curr Opin Support Palliat Care 2020;14:286-92. [PMID: 32740273 DOI: 10.1097/SPC.0000000000000505] [Reference Citation Analysis]
108 Mercantepe F, Mercantepe T, Topcu A, Yılmaz A, Tumkaya L. Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury. Naunyn-Schmiedeberg's Arch Pharmacol 2018;391:915-31. [DOI: 10.1007/s00210-018-1514-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]